These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 8978837
41. Quantitative structure-activity relationships for the pre-steady state acetylcholinesterase inhibition by carbamates. Lin G, Liao WC, Chan CH, Wu YH, Tsai HJ, Hsieh CW. J Biochem Mol Toxicol; 2004; 18(6):353-60. PubMed ID: 15674842 [Abstract] [Full Text] [Related]
43. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors. Wilcox RE, Tseng T, Brusniak MY, Ginsburg B, Pearlman RS, Teeter M, DuRand C, Starr S, Neve KA. J Med Chem; 1998 Oct 22; 41(22):4385-99. PubMed ID: 9784114 [Abstract] [Full Text] [Related]
45. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Saxena A, Redman AM, Jiang X, Lockridge O, Doctor BP. Biochemistry; 1997 Dec 02; 36(48):14642-51. PubMed ID: 9398183 [Abstract] [Full Text] [Related]
46. Molecular docking studies of natural cholinesterase-inhibiting steroidal alkaloids from Sarcococca saligna. Zaheer-Ul-Haq ZU, Wellenzohn B, Liedl KR, Rode BM. J Med Chem; 2003 Nov 06; 46(23):5087-90. PubMed ID: 14584959 [Abstract] [Full Text] [Related]
51. 3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies. Thaimattam R, Daga P, Rajjak SA, Banerjee R, Iqbal J. Bioorg Med Chem; 2004 Dec 15; 12(24):6415-25. PubMed ID: 15556759 [Abstract] [Full Text] [Related]
52. Structure-activity relationships and binding mode in the human acetylcholinesterase active site of pseudo-irreversible inhibitors related to xanthostigmine. Rizzo S, Cavalli A, Ceccarini L, Bartolini M, Belluti F, Bisi A, Andrisano V, Recanatini M, Rampa A. ChemMedChem; 2009 Apr 15; 4(4):670-9. PubMed ID: 19222043 [Abstract] [Full Text] [Related]
53. Dynamic mechanism of E2020 binding to acetylcholinesterase: a steered molecular dynamics simulation. Niu C, Xu Y, Xu Y, Luo X, Duan W, Silman I, Sussman JL, Zhu W, Chen K, Shen J, Jiang H. J Phys Chem B; 2005 Dec 15; 109(49):23730-8. PubMed ID: 16375354 [Abstract] [Full Text] [Related]
58. "Back door" opening implied by the crystal structure of a carbamoylated acetylcholinesterase. Bartolucci C, Perola E, Cellai L, Brufani M, Lamba D. Biochemistry; 1999 May 04; 38(18):5714-9. PubMed ID: 10231521 [Abstract] [Full Text] [Related]
59. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics. Kwon YE, Park JY, No KT, Shin JH, Lee SK, Eun JS, Yang JH, Shin TY, Kim DK, Chae BS, Leem JY, Kim KH. Bioorg Med Chem; 2007 Oct 15; 15(20):6596-607. PubMed ID: 17681794 [Abstract] [Full Text] [Related]